Matthew Herper· @matthewherper · X·· 23 小时前AI 评分22
AI 导读
十年前,中国制药业主要以仿制西方药物闻名。如今,跨国制药巨头斥资数十亿美元购买中国的科学进展。为描绘这一转变,STAT与Wirescreen评选出25家最具价值的公开上市中国药企,这些企业专注于发现和开发专有药物。 https://www.statnews.com/china-biotech-index-powerhouse-25/
正文
A decade ago, China’s pharmaceutical industry was known primarily for copying Western drugs. Today, multinational pharma giants pay billions for Chinese scientific advances. To map this shift, STAT and Wirescreen ranked the 25 most valuable publicly traded Chinese drugmakers focused on discovering and developing proprietary medicines.
https://www.statnews.com/china-biotech-index-powerhouse-25/
来源:Matthew Herper · x.com